Reyes Financial Architecture, Inc.

Position in EXEL — Exelixis, Inc.

CIK 2047201 SAN DIEGO, CA

Position in EXEL

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$88,361

+$33,634 QoQ

Shares Held

1,624

+27.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#153

of 228 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Reyes Financial Architecture, Inc. holds $129,824 across 5 Biotechnology names. EXEL ranks #1 (68.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc. This page	1,624	$88,361
2	KRYS	Krystal Biotech, Inc.	100	$37,167
3	VRTX	Vertex Pharmaceuticals Inc / Ma	8	$3,973
4	GTBP	GT Biopharma, Inc.	625	$306
5	CLDI	Calidi Biotherapeutics, Inc.	100	$17

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$88,361	1,624	+27.3%	Shares	Sole	2026-07-17
2026-03-31	$54,727	1,276	-33.5%	Shares	Sole	2026-05-12
2025-12-31	$84,109	1,919	-17.5%	Shares	Sole	2026-01-26
2025-09-30	$96,105	2,327	-15.3%	Shares	Sole	2025-11-12
2025-06-30	$121,131	2,748	-32.9%	Shares	Sole	2025-07-09
2025-03-31	$151,298	4,098	—	Shares	Sole	2025-05-01
No filing history on record for this holder in this stock.